Literature DB >> 2458484

A retroviral RNA secondary structure required for efficient initiation of reverse transcription.

D Cobrinik1, L Soskey, J Leis.   

Abstract

Genetic evidence is presented which suggests the existence of an important structural element in the 5' noncoding region of avian retrovirus RNA. The proposed structure, which we term the U5-leader stem, is composed of sequences in the middle of U5 and in the leader, flanking the primer-binding site. U5 and leader mutations which would disrupt this structure caused a partial replication defect. However, nucleotide substitutions in the leader, which would structurally compensate for a U5 deletion mutation, restored normal replication. Analysis of replication intermediates of viruses with the above mutations suggests that the U5-leader stem is required for efficient DNA synthesis in vivo and for initiation of DNA synthesis from the tRNA(Trp) primer in melittin-activated virions. However, this structure does not appear to be required for binding of the tRNA(Trp) primer to viral RNA. These results support a role for the U5-leader stem structure, independent of its primary sequence, in the initiation of retroviral replication.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458484      PMCID: PMC253503     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Isolation and characterization of a large "hairpin" segment from avian retrovirus RNA.

Authors:  M L Perdue; W Wunderli; W K Joklik
Journal:  Virology       Date:  1979-05       Impact factor: 3.616

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information.

Authors:  M Zuker; P Stiegler
Journal:  Nucleic Acids Res       Date:  1981-01-10       Impact factor: 16.971

4.  Products of reverse transcription in avian retrovirus analyzed by electron microscopy.

Authors:  R P Junghans; L R Boone; A M Skalka
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

5.  Secondary structural features in the 70S RNAs of Moloney murine leukemia and Rous sarcoma viruses as observed by electron microscopy.

Authors:  K G Murti; M Bondurant; A Tereba
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

6.  Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. I. Kinetics of synthesis and size of minus- and plus-strand transcripts.

Authors:  L R Boone; A M Skalka
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

7.  Interaction of psoralen derivatives with the RNA genome of Rous sarcoma virus.

Authors:  R Swanstrom; L M Hallick; J Jackson; J E Hearst; J M Bishop
Journal:  Virology       Date:  1981-09       Impact factor: 3.616

8.  Avian oncovirus mutant (SE21Q1b) deficient in genomic RNA: characterization of a deletion in the provirus.

Authors:  P R Shank; M Linial
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

9.  Analysis of the secondary and tertiary structures of Rous sarcoma virus RNA.

Authors:  J L Darlix; M Schwager; P F Spahr; P A Bromley
Journal:  Nucleic Acids Res       Date:  1980-08-11       Impact factor: 16.971

10.  Moloney murine sarcoma proviral DNA is a transcriptional unit.

Authors:  E W Benz; R M Wydro; B Nadal-Ginard; D Dina
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

View more
  61 in total

1.  Substrate sequence selection by retroviral integrase.

Authors:  H Zhou; G J Rainey; S K Wong; J M Coffin
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication.

Authors:  A H Lund; M Duch; F S Pedersen
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

3.  Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.

Authors:  N Beerens; F Groot; B Berkhout
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

4.  A mutation in the short 5'-proximal open reading frame on Rous sarcoma virus RNA alters virus production.

Authors:  R B Petersen; A Moustakas; P B Hackett
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

5.  Identification of sequences downstream of the primer binding site that are important for efficient replication of human immunodeficiency virus type 1.

Authors:  X Li; C Liang; Y Quan; R Chandok; M Laughrea; M A Parniak; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Tat is required for efficient HIV-1 reverse transcription.

Authors:  D Harrich; C Ulich; L F García-Martínez; R B Gaynor
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

7.  Does the HIV-1 primer activation signal interact with tRNA3(Lys) during the initiation of reverse transcription?

Authors:  Valérie Goldschmidt; Chantal Ehresmann; Bernard Ehresmann; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

8.  Structure-function relationships of the initiation complex of HIV-1 reverse transcription: the case of mutant viruses using tRNA(His) as primer.

Authors:  Mickaël Rigourd; Valérie Goldschmidt; Fabienne Brulé; Casey D Morrow; Bernard Ehresmann; Chantal Ehresmann; Roland Marquet
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

9.  Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion.

Authors:  P Olson; H M Temin; R Dornburg
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Authors:  E Vicenzi; D S Dimitrov; A Engelman; T S Migone; D F Purcell; J Leonard; G Englund; M A Martin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.